Taevas
Taevas Global acts as your in-country legal representative across 120+ markets, ensuring your life sciences products meet every regulatory, commercial, and compliance requirement from day one.
Legal Representation is the formal appointment of a qualified in-country entity to act on behalf of a foreign life sciences manufacturer before regulatory authorities, healthcare institutions, and commercial partners. It is a mandatory requirement in many jurisdictions for product registration, post-market surveillance, and ongoing compliance.
Taevas Global combines deep regulatory expertise with on-the-ground legal infrastructure across every major life sciences market. We do not simply hold a designation — we actively manage correspondence, maintain dossiers, coordinate with competent authorities, and protect your commercial interests throughout the product lifecycle.
One trusted partner. Every market. Full accountability from submission to post-market.
We communicate directly with national competent authorities on your behalf, managing submissions, queries, and compliance correspondence efficiently.
Our teams maintain complete, up-to-date regulatory dossiers and ensure all documentation meets jurisdiction-specific formatting and content requirements.
We monitor post-market surveillance obligations, adverse event reporting timelines, and renewal schedules to keep your registrations in good standing.
We align legal representation duties with your distributor and procurement agreements, ensuring seamless coordination across all commercial stakeholders.
Our Legal Representation framework is built on six interconnected pillars that together ensure your products remain compliant, competitive, and commercially active in every market you enter.
Taevas formally accepts appointment as your legal representative under applicable national and regional regulations. We execute all required mandate documentation with competent authorities and maintain an auditable record of our appointment status across every jurisdiction.
We proactively identify and mitigate compliance risks arising from regulatory changes, labeling updates, and evolving post-market requirements. Our risk management protocols are designed specifically for the life sciences sector and updated continuously as legislation evolves.
Our in-country teams track legislative amendments, guidance updates, and authority decisions that affect your product categories. You receive timely alerts and actionable summaries so your regulatory strategy stays ahead of the curve.
From initial submission through renewal and variation management, we own the end-to-end registration process. We track all deadlines, prepare renewal packages, and coordinate variation filings to prevent lapses in your market authorizations.
For companies operating across multiple jurisdictions, we provide a single coordinated interface that harmonizes representation activities, aligns timelines, and reduces duplication of effort. Our global network ensures consistent standards regardless of geography.
Clients receive structured dashboards and periodic status reports covering registration status, upcoming deadlines, authority correspondence, and compliance milestones. Transparent reporting gives leadership teams full visibility into regulatory standing at all times.
A structured four-stage process that balances speed with rigour — typically complete in 4–6 weeks.
We align on objectives, geographies, therapy areas, and the specific business questions that need answering.
A 30–45 minute scoping call establishes the intelligence framework — ensuring every subsequent research hour is focused on decisions that matter.
Our Legal Representation capabilities are tailored to the distinct regulatory environments and commercial dynamics of every life sciences sector.
From branded generics to biologics, we cover the full pharmaceutical value chain — clinical pipeline tracking, patent cliff analysis, and reimbursement modelling across regulated and emerging markets.
Our Legal Representation network spans every major life sciences market, providing consistent, accountable in-country presence wherever your products need to be registered and sold.
India · China · Japan · South Korea · Australia · Indonesia · Thailand · Vietnam · Philippines
Germany · France · UK · Italy · Spain · Netherlands · Switzerland · Poland · Sweden
United States · Canada · Brazil · Mexico · Colombia · Argentina · Chile
UAE · Saudi Arabia · Turkey · Israel · Egypt · Qatar
South Africa · Nigeria · Kenya · Ethiopia · Morocco
Bangladesh · Sri Lanka · Pakistan · Nepal · Myanmar
Every Legal Representation engagement includes a comprehensive set of deliverables designed to give you complete regulatory coverage, full transparency, and zero compliance gaps.
TAM/SAM/SOM with 5-year projections, segmented by product type, end user, and geography.
Profiling of top 10–15 players with pipeline, financials, positioning, and SWOT analysis.
Step-by-step approval guide, typical timelines, required dossiers, and local partner requirements.
Benchmark pricing across channels, reimbursement eligibility, and HTA decision landscape.
Prioritised strategy with recommended partnerships, channels, and launch sequencing.
Key opinion leaders, payer organisations, and the distributor ecosystem across target markets.
Interactive data visualisation summarising findings for C-suite and board presentations.
Post-delivery support to clarify findings, run scenario analyses, or refine recommendations.
Legal Representation from Taevas is designed for every stakeholder responsible for getting life sciences products into global markets safely, legally, and efficiently.
Evaluating new market entry, product launches in new geographies, or acquisitions requiring deep commercial due diligence.
Conducting commercial due diligence, validating market size assumptions, or assessing competitive moats before committing capital.
Seeking investor-grade market data to underpin fundraising narratives, identify first-mover opportunities, or prioritise expansion.
Understanding sector landscapes, benchmarking policy environments, and identifying foreign investment opportunities in health and life sciences.
Translating academic research into commercial potential assessments, technology transfer opportunities, and licensing strategy.
White-label intelligence support for strategy and management consulting firms advising clients across life sciences markets.
Our analysts work exclusively in pharma, medtech, and consumer health. Every report reflects deep domain expertise — not generic research methodology applied to healthcare.
We don’t just aggregate public data. Every engagement includes primary interviews with regulators, KOLs, payers, and channel partners — intelligence you can’t Google.
Our network spans India, Southeast Asia, MENA, and Sub-Saharan Africa — markets that generic firms cover superficially but where the greatest growth opportunities exist.
We write for decision-makers, not archives. Every report includes a clear recommendation. Our readout sessions are structured for board discussions, not just information transfer.
Rapid-response turnarounds of 2–4 weeks for focused engagements — without sacrificing the rigour of primary research and expert validation.
Our 30-day Q&A window, ongoing subscriptions, and retainer models mean we’re a long-term intelligence partner — not a one-off vendor.
“Taevas took over our legal representation across eleven markets within six weeks and immediately resolved two pending authority queries that had stalled our registrations for months. Their proactive approach and local knowledge are genuinely unmatched.”
Legal Representation is the foundation — pair it with these complementary Taevas services to build a complete market entry and compliance strategy.
From regulatory pathway mapping to full dossier preparation and submission management across global markets.
Shortlisting, evaluating, and connecting you with validated in-market partners, distributors, and licensing candidates.
Optimise launch pricing, reimbursement positioning, and access pathways to maximise commercial success from day one.
Scientific communication strategy, publication planning, and structured KOL engagement programmes for new market entrants.
Investor-grade commercial assessments for M&A, licensing deals, or fundraising — with rapid turnaround for live transactions.
Monthly or quarterly market monitoring — competitive signals, regulatory updates, and commercial developments as a managed service.
Whether you are entering a new market, transferring an existing mandate, or building a multi-market representation structure, Taevas Global is ready to act as your trusted in-country legal representative from day one.